This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Medifast (MED) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medifast's (MED) OPTAVIA System a Key Driver, SG&A Costs High
by Zacks Equity Research
Medifast (MED) has long been gaining on the strength of its OPTAVIA lifestyle solution and coaching support system, while rising SG&A costs are a worry.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Kimberly-Clark (KMB) on Track With Saving Efforts Amid Cost Woes
by Zacks Equity Research
Kimberly-Clark (KMB) is committed toward saving actions, which are likely to help the company amid the rising cost challenges.
McCormick's (MKC) Q3 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
McCormick's (MKC) third-quarter fiscal 2021 results reflect the impact of higher sales driven by growth in the Flavor Solutions and Consumer units. Management updates fiscal 2021 sales view upward.
Hershey (HSY) Benefits From Prudent Buyouts, Hurt by Costs
by Zacks Equity Research
Hershey (HSY) strategically increases its presence through acquisitions to expand its portfolio. However, increased packaging and freight costs are a concern.
Kraft Heinz (KHC) Gains on Pricing Efforts Amid Cost Hurdles
by Zacks Equity Research
Kraft Heinz's (KHC) solid pricing initiatives are working favorably. Also, the company's operating model looks promising.
United Natural's (UNFI) Q4 Earnings Top Estimates, Shares Rally
by Zacks Equity Research
United Natural's (UNFI) fourth-quarter fiscal 2021 results reflect year-over-year growth in earnings as well as a sequential increase in sales. The company is well placed for fiscal 2022.
Kraft Heinz's (KHC) Hemmer Buyout to Grow Taste Elevation Platform
by Zacks Equity Research
Kraft Heinz (KHC) will acquire the Brazil-based condiments and sauces company, Hemmer. The move will expand the company's footprint across emerging markets.
Sysco's (SYY) Cutting Edge Solutions Products to Fuel Growth
by Zacks Equity Research
Sysco (SYY) unveils eight innovative concepts through the company's Cutting Edge Solutions platform, which is likely to enhance its customers' experience.
General Mills' (GIS) Q1 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
General Mills' (GIS) first-quarter fiscal 2022 results reflect higher sales driven by solid performance across most segments. However, earnings decline year over year.
B&G Foods (BGS) Hurt by Cost Inflation, Down 10% in 6 Months
by Zacks Equity Research
B&G Foods (BGS) is encountering coronavirus-related costs for the past few quarters. Also, higher cost inflation is affecting gross margin performance.
Medifast (MED) Worth Relishing on OPTAVIA Strength, Growth Plans
by Zacks Equity Research
Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system as well as focus on capacity expansion and technological advancements.
Helen of Troy (HELE) Up on Solid Leadership Brands & Online Sales
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in the Leadership Brands. Also, the company is gaining from its consistent online sales.
Kellogg (K) Gains on Emerging Market Strength, Costs Flare Up
by Zacks Equity Research
Kellogg (K) is gaining on its solid emerging market performance as well as brand strength. However, the company expects elevated cost inflation in the second half of 2021.
Flowers Foods' (FLO) Core Strategies Aid, Costs Flare Up
by Zacks Equity Research
Flowers Foods (FLO) is on track with its core priorities and pricing efforts. However, the company expects to see significant cost inflation in the near term.
Philip Morris (PM) Secures More than 74% Stake in Vectura
by Zacks Equity Research
Philip Morris (PM) secures more than 74% of Vectura's shares to become a majority stakeholder. The company expects to amplify growth in its Beyond Nicotine strategy via this move.
Philip Morris (PM) Buys Fertin Pharma, Announces Dividend Hike
by Zacks Equity Research
Philip Morris (PM) buys Fertin Pharma to attain its target of becoming a majority smoke-free company by 2025. The company also raises its quarterly dividend.
Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Pilgrim's Pride (PPC) Looks Solid: Up More Than 20% in 3 Months
by Zacks Equity Research
Pilgrim's Pride's (PPC) focus on key customers is a pathway for refining portfolio and building competitive advantages. Solid performance across all regions in the second quarter bodes well.
5 Top-Ranked Stocks Backed by DuPont Technique for Solid Returns
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Hershey (HSY) Gains on Prudent Acquisitions & Brand Strength
by Zacks Equity Research
Hershey (HSY) makes several strategic acquisitions to enhance its brand portfolio. The company's solid pricing initiatives are also yielding.
Service Corporation (SCI) Looks Solid: Up More Than 15% in 3 Months
by Zacks Equity Research
Service Corporation (SCI) is in a robust shape, thanks to the stellar Cemetery segment revenues as well as stringent cost control.
Helen of Troy (HELE) Rewards Shareholders, Unveils New Buybacks
by Zacks Equity Research
Helen of Troy (HELE) approves repurchase of shares worth $500 million to return capital not otherwise deployed toward strategic buyouts or core business growth.
Kraft Heinz (KHC) Brings Agility to Scale, Operating Model Solid
by Zacks Equity Research
Kraft Heinz (KHC) is benefiting from incorporating agility to its scale along with strength in the operating model. Management expects to post adjusted EBITDA of more than $6.1 billion in 2021.